Microvascular and macrovascular benefits of GLP-1 receptor agonists

Newark, DE US
March 17, 2020

This presentation is designed for pharmacists and pharmacy technicians at ChristianaCare Hospital.  It will address current diabetes treatment guidelines and the data evaluating the effects GLP-1 RAs have on microvascular and macrovascular complications and describe the proposed mechanism by which GLP-1 RAs reduce cardiovascular risk in patients with type 2 diabetes mellitus (T2DM). Pharmacists will review the mechanism of action of GLP-1 receptor agonist, discern between management of glucose metabolism and the reduction in CVD. By the end of this presentation pharmacist will be able to identify which GLP-1 RA have been indicated to reduce CVD and reduce mortality.

Target Audience

  • Pharmacists
  • Pharmacy technicians

Learning Objectives

Pharmacist learning objectives

  1. Describe the mechanism of action, efficacy and common adverse drug reactions associated with GLP-1 RA agents
  2. Discuss the data surrounding microvascular and macrovascular effects of GLP-1 RA agents
  3. Use available data and the 2020 American Diabetes Association (ADA) guidelines and 2020 American Association of Clinical Endocrinologists (AACE)/American College of Endocrinology (ACE) guidelines to determine GLP-1 RA place in therapy

Pharmacy technician learning objectives

  1. List the FDA approved GLP-1RA agents

Additional Information

AttachmentSize
Helpful Tips for Users.docx23.3 KB
Information for CE Credit - Mar 17 2020.docx124.3 KB
Course summary
Available credit: 
  • 1.00 ACPE Pharmacy
  • 1.00 ACPE Technician
  • 1.00 General CEU – Attendance
Course opens: 
03/17/2020
Course expires: 
04/30/2020
Event starts: 
03/17/2020 - 12:00pm
Event ends: 
03/17/2020 - 1:00pm
Cost:
$0.00
Add to calendar: 
ChristianaCare Health System
4755 Ogletown-Stanton Rd.
Newark, DE 19713
United States
Relevant financial relationships: Planning committee members and the presenter have nothing to disclose
 
Planning committee members
Amanda Schartel, PharmD, BCACP
Clinical Pharmacist Specialist
ChristianaCare
 
Julie Dally, PharmD, BCPS, BCACP
Clinical Pharmacist
ChristianaCare
 
Huda Eldabbas, PharmD
Pharmacist
ChristianaCare
 
Course reviewer
Katrina K. Harper, PharmD, MBA, BCPS, BCSCP
Clinical Pharmacy Director, Sourcing Operations
Center for Pharmacy Practice Excellence
Vizient
 
Presenter
Huda Eldabbas, PharmD
Pharmacist
ChristianaCare
Joint Accreditation Statement:
 
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and ChristianaCare Health System.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
____________________________________________
 
Designation Statements:
 
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-20-049-L01-P
Universal Activity Number: JA0006103-9999-20-049-L01-T
 
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacy
  • 1.00 ACPE Technician
  • 1.00 General CEU – Attendance

Price

Cost:
$0.00
Please login or register to take this course.